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The structure of the putative T  cell antigen  receptor has been defined using 
monoclonal antibodies (mAb) 1 prepared against various monoclonal T  cell pop- 
ulations in several laboratories (1-3),  including our own (4,  5).  These reagents 
have  defined  an  80-90  kilodalton  (kD)  disulfide-linked  heterodimer  usually 
composed of a 49-53  kD alpha chain of acidic pI and a 41-43 kD beta chain of 
more basic pI.  These heterodimeric molecules fulfill certain anticipated charac- 
teristics  for  the  T  cell  antigen  receptor,  i.e.,  the  presence  of idiotypy  (1-6), 
homology of the gene sequences to immunoglobulin  (7-10), and the capacity to 
block the function of antigen-specific T  cell lines or hybridomas when complexed 
with mAb that detect private idiotypes on the molecule (2, 3, 6). An additional 
functional characteristic  expected of the T  cell receptor is the ability to specifi- 
cally mediate stimulation  of resting T  cells after interaction  with antigen.  This 
issue has been  approached  previously by using  mAb that  bind  to the  variable 
region  of the antigen  receptor on activated cells, such as interleukin  2  (IL-2)- 
dependent T  cell lines, T-T hybridomas, or human T  cell leukemias that express 
the Tac antigen.  When present either as soluble or Sepharose-bound antibody, 
these mAb have been shown (2, 3, 5, 6) to specifically increase IL-2 production 
or  DNA  synthesis  in  these  previously  activated  cells.  However,  since  these 
antibodies  bind  to  private  idiotypic specificities,  they have  not  been  useful  in 
demonstrating  a  comparable pattern  of activation  with  normal  resting  T  cells. 
Recently,  heteroantisera  (11,  12)  and  mAb  (4,  13)  have  been  described  that 
detect common determinants on the T  cell antigen receptor expressed on normal 
T  cells. Although these reagents confirm the presence of this molecule on normal 
T  cells, they have not been reported to stimulate the reactive cells. 
In  a  previous  report  (4),  we described an  antibody  reacting  with  the  T  cell 
antigen receptor on a subpopulation of normal circulating  human  T  cells. This 
mAb,  $511,  was produced  using a  human  T  cell  leukemia as the  immunogen 
and  was shown  to  immunoprecipitate  an  80  kD,  disulfide-linked  heterodimer 
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composed of a  43 kD chain and a  38 kD chain on the leukemic cells. In addition 
to reacting with  the  leukemic T  cells,  this antibody was shown to react with  1- 
2% of circulating T  cells in all individuals tested. The current study was initiated 
to  investigate the  nature  of these  reactive cells and  to  test  the  hypothesis  that 
binding of mAb $511  to  these cells would  result  in  the  activation of resting T 
lymphocytes. The data demonstrate that the population of normal T  lymphocytes 
reactive  with  $511  is  composed  of  resting  cells  and  that  both  soluble  and 
Sepharose-bound antibody induce proliferation of these cells.  Additionally,  the 
$511  molecules on the normal $511-bearing T  lymphocytes appear to be similar 
to  those  on  the  original  leukemic  cells.  A  preliminary report  of these  findings 
has been presented (14). 
Materials and  Methods 
Monoclonal  Antibodies.  Preparation and characterization of the murine mAb $511  has 
been previously described (4).  The $511  mAb, an IgG2bK antibody, was purified from 
ascites by fractionation  with  50% ammonium sulfate and elution  from DEAE cellulose 
(DE-52;  Whatman,  Inc.,  Clifton,  NJ)  using  a  0-0.2  M  NaCl  gradient.  This antibody 
preparation was coupled to cyanogen bromide-activated Sepharose 4B beads (Pharmacia 
Fine Chemicals,  Piscataway, NJ) at a ratio of 6  mg protein bound to 0.5  g beads using 
standard  conditions.  A  control  mAb  reacting  with  the  hapten  dinitrophenyl  (DNP) 
(provided by Dr.  D.  H. Katz, Medical Biology Institute,  La Jolla, CA) was prepared in 
the  same  manner  as  $511.  Antibodies  OKT-3,  OKT-4,  and  OKT-8  were  obtained 
commercially (Ortho Diagnostic Systems, Inc., Raritan, NJ) and mAb 9.6 was the gift of 
Dr. John Hansen, Fred Hutchinson Cancer Research Center, Seattle, WA. 
Stimulation of Normal T Cells.  Peripheral blood mononuclear cells were obtained and 
separated by rosetting with neuraminidase-treated sheep erythrocytes. Autologous non- 
rosetting cells were irradiated at 3,000 rad and mixed with rosetting cells at a  I:I0 ratio 
when  indicated.  These cells were cultured  in  RPMI  1640  medium supplemented  with 
20% human AB serum and serial dilutions of purified mAb, phytohemagglutinin (PHA) 
(Gibco Laboratories, Grand Island, NY), or 10% lectin-free IL-2 (Electro-Nucleonics Inc., 
Fairfield, N  J). Cells were cultured for 9 d  in flat-bottom microtiter plates (Linbro; Flow 
Laboratories, Inc., McLean, VA) and then analyzed for [3H]thymidine incorporation on 
alternate days.  Proliferation was calculated from the  mean thymidine incorporation of 
quadruplicate  samples of cells  cultured  in  the  presence  of mAb  compared  with  cells 
cultured  in  media alone.  Data are expressed as a proliferation index: (antibody culture 
mean cpm)/(media culture mean cpm). 
Simultaneous  Surface  Immunofluorescence  and  DNA  Cell  Cycle Analysis.  T  cells  were 
obtained by sheep erythrocyte rosetting and were stained by indirect immunofluorescence 
with mAb and fluorescein isothiocyanate-conjugated (FITC) goat anti-mouse immuno- 
globulin  (Tago,  Inc.,  Burlingame,  CA)  in  saturating  conditions.  For  DNA  cell  cycle 
analysis, these cells were fixed overnight in 70% ethanol, washed, and suspended at 5 × 
105/ml in phosphate-buffered saline containing 18 #g/ml propidium iodide and 40 •g/ml 
RNase (Sigma Chemical Co., St.  Louis, MO) (15).  After 30 min the cells were analyzed 
for simultaneous surface FITC fluorescence and DNA fluorescence using a  50-H Cyto- 
fluorograf (Ortho Diagnostic Systems). 
Generation  of $51 I-reactive  T  Cell Lines.  Five million peripheral blood T  cells were 
suspended in 0.5 ml of RPMI 1640 medium with 10% fetal calf serum, to which an equal 
volume of 2% $511-Sepharose 4B beads was added. The suspension was centrifuged and 
then  incubated  at 4°C  for 30  min.  The pellet was gently resuspended  and the  $511- 
Sepharose was allowed to settle in a  conical tube for  15  min. After settling, the $511- 
Sepharose and any bound cells were removed from the bottom of the tube and placed in 
medium containing  10%  IL-2.  Proliferating cells were expanded  in  this  medium with 
addition  of new  $511-Sepharose  every  7-10  d.  The  surface  molecules on  a  cell  line 
obtained  using this  method  and  on the  original  leukemic cells were  ~sI-labeled using 1452  RESTING  T  CELL  ACTIVATION  BY  ANTIRECEPTOR  ANTIBODY 
lactoperoxidase,  immunoprecipitated with mAb $511, and analyzed  by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as previously described (4, 5). 
Results 
Induction  of T  Cell  Proliferation  by  Soluble  $511.  Our  previous  study  (4) 
demonstrated that  1-2% of circulating peripheral blood T  cells from all individ- 
uals tested were $511 +. If the $511 molecule represents the antigen receptor on 
these normal T  lymphocytes, then $511 antibody binding may specifically induce 
activation and proliferation of these normal cells in a manner similar to specific 
antigen-induced  activation.  This hypothesis was evaluated by obtaining periph- 
eral blood T cells from three individuals with 1.5-2.6% circulating $511-reactive 
T  cells. These cells were cultured for 9 d in the presence of soluble mAb, either 
$511  or anti-DNP,  and  irradiated  nonrosetting  cells.  Cultures  from  all  three 
individuals demonstrated  T  cell proliferation  when cultured with $511  and no 
proliferation  when  cultured  with  anti-DNP.  The  results  of the  proliferation 
induced on sequential days by mAb $511 and anti-DNP at 1.6 #g/ml are displayed 
in Fig.  1. They demonstrate that, over 9 d, the proliferation index for anti-DNP 
was between 0.6 and 2.0 for all three individuals, while the $511 mAb consistently 
induced proliferation starting on day 3 with an index of 3.0-17.2. The stimula- 
tion on day 3 continued and reached a maximum on day 7, with the proliferation 
index ranging  between 41.6 and  185.1.  After this peak of activation on day 7, 
the amount of thymidine incorporated on day 9 decreased, presumably due to 
extensive cell proliferation and limitations  of the culture conditions. Additional 
experiments were also performed using the previously described mAb S 160 (4) 
as  the  control  antibody.  This  mAb  detects  a  private  idiotope  of the  antigen 
receptor molecule on the same leukemic cells used to generate mAb $511.  As 
with anti-DNP, mAb S 160 also failed to activate normal T  cells (data not shown). 
The dependence of this stimulation on antibody concentration  and the pres- 
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FIGURE  1.  Proliferation of normal resting T  cells induced by mAb $511  (0) or mAb anti- 
DNP  (X)  at  1.6  /~g/ml  of soluble antibody.  T  lymphocytes from  three  different normal 
individuals were analyzed for [3H]thymidine incorporation. Data are presented as a prolifera- 
tion index: (mean cpm of cells cultured in antibody)/(mean cpm of cells cultured in media 
alone). BIGLER,  POSNETT,  AND  CHIORAZZI  1453 
ence of autologous nonrosetting cells was evaluated. Initial experiments used the 
same culture conditions as above, which contained  10% irradiated nonrosetting 
cells.  Table I  demonstrates  that,  over a  range of antibody concentration from 
0.01  to  10 #g/ml,  proliferation was  not  induced  by anti-DNP.  However, over 
TABLE  I 
Normal T Cell Proliferation Induced by Monoclonal Antibody $511 
T  cells +  non-T cells*  T  cells alone* 
Day 3  Day 7  Day 3  Day 7 
Anti-DNP 
10~g/ml  1.1  1.6  0.9  1.5 
1  1.2  1.2  1.0  1.2 
0.1  1.1  1.8  0.8  1.0 
0.01  1.0  0.9  0.9  1.4 
$511 
10 t~g]ml  3.3  61.3  1.7  79.9 
1  2.8  49.3  2.0  126.8 
0.1  1.1  2.0  1.1  14.3 
0.01  7.9  1.0  1.2  2.6 
IL-2  a 10%  2.4  22.0  ND  j  ND 
PHA 1:100  221.8  9.9  213.6  20.6 
* Mean  proliferation indices of three experiments. Cultures contained 
10% irradiated nonrosetting cells. 
* Mean proliferation indices of two experiments using sheep erythrocyte- 
rosetted cells without the addition of nonrosetting cells. 
0 Lectin-poor, 1L-2-supplemented media without the addition of mAb. 
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FIGURE 2.  Fluorescence histograms of normal T  ceils stimulated by mAb or IL-2. (A-C) T 
cells were cultured for 7 d with 10% irradiated non-T cells and antibody. After two additional 
days of growth in media containing 10%  IL-2 without antibody, the cells were washed and 
stained by indirect immunofluorescence with FITC GAMG alone (- -  -) or mAb $511  plus 
FITC GAMG (--). (A) Cells cultured in $511  at 1.6 tzg/ml. (B) Cells cultured in anti-DNP at 
1.6 #g/ml. (C) Cells cultured in  10%  IL-2 alone. (D) An lL-2-dependent T  cell line activated 
by $511-Sepharose. 1454  RESTING  T  CELL ACTIVATION BY  ANTIRECEPTOR ANTIBODY 
this same range  mAb $511  induced about a  threefold increase in proliferation 
on day 3 and a concentration-dependent maximum proliferation on day 7 of 49- 
61 times greater than background. This same concentration range was examined 
for stimulation of T  cells without the addition of non-T cells as accessory cells. 
As before, no stimulation occurred with anti-DNP. The $511 cultures, however, 
showed a twofold increase on day 3 and a pronounced concentration-dependent 
proliferation  on day 7.  The proliferation  on day 7 in these T  cell cultures was 
comparable to that  observed in cultures  to which irradiated  nonrosetting  cells 
were added. The extensive proliferation induced by mAb $511  is striking when 
one compares the  proliferation  index  of $511  cultures  (127  on day 7),  which 
activates 2% of the T  cells in culture, and the proliferation  index of PHA (214 
on day 3), which activates the majority of T  cells in culture. 
The thymidine  incorporation  observed in  the $511  cultures could represent 
either specific proliferation  of the $511-bearing  cells or nonspecific expansion 
of recruited  cells.  The  latter  was  especially  possible  since  some  proliferation 
occurred in the IL-2 cultures without the addition of antibody (Table I).  Thus, 
the  nature  of the  proliferating  cells in  IL-2  containing  cultures  and  antibody- 
containing cultures was examined. T  cells were cultured in the presence of either 
$511,  anti-DNP,  IL-2, or  PHA and  additional  irradiated  non-T  cells,  washed 
twice in  media  on  day  7,  and  then  cultured  for two additional  days in  media 
containing  10%  IL-2.  The  results of immunofluorescence  staining at this  time 
showed that, in $51 l-stimulated cultures, 34% of the cells were $511 + (Fig. 2A), 
88% were OKT-3  ÷, and 40% were Ia  +. This expansion of the $511  population 
compares with 0.9% $511 + cells in the anti-DNP cultures (Fig. 2B) and  1.9% in 
the media control cultures.  Fluorescence staining of cells activated by PHA for 
either  3  or 7 d  also showed only 2.2 or  1.2%  $511-bearing cells, respectively. 
Those  cells  activated  by  the  IL-2  preparation  were  also  analyzed  for  $511 
expression.  As  shown  in  Fig.  2C,  only  0.6%  of these  proliferating  cells were 
$511 +.  Thus,  the proliferating  cell in  the  $511-stimulated  culture is primarily 
the $511-bearing lymphocyte rather than nonspecifically recruited cells, and the 
proliferation  observed  in  the  IL-2-containing  cultures  (Table  I)  is  not  due  to 
selective expansion of $511-reactive cells. 
Cell Cycle Analysis  of Circulating  S511-bearing  T Lymphocytes.  The preceding 
experiments  indicate that  mAb $511  could specifically activate the circulating 
$511-reactive  cell in  normal  individuals.  Previous studies (2,  3,  5,  6) in  which 
cells were stimulated with mAb detecting the T  cell antigen receptor have used 
cells that  were previously activated.  To  investigate  whether  the  $511-bearing 
cell was resting or was previously activated and therefore analogous to these cell 
lines, T  lymphocytes reacting with mAb $511 were studied by cell cycle analysis. 
T  lymphocytes were stained by indirect immunofluorescence  with either the 
second antibody, FITC-conjugated goat anti-mouse immunoglobulin  (GAMG), 
alone or with mAb 9.6,  which detects the sheep erythrocyte receptor,  or mAb 
$511.  After  surface  staining  and  fixation,  the  cells  were  analyzed  for  DNA 
content measured by propidium  iodide fluorescence. To discriminate  between 
single cells in the S+G~/M phase of the cell cycle and clumps of cells artifactually 
induced by the fixation procedure, the initial gating for flow cytometry compared 
pulse width vs. pulse area of the red  DNA fluorescence signal.  For a  clump of BIGLER,  POSNETT,  AND  CHIORAZZI  1455 
cells, such as a doublet with a diploid chromosome number in each cell, the total 
DNA fluorescence will  be  the same as a  single dividing cell with a  tetraploid 
chromosome  number;  however,  the  time  of flight across  the  laser  beam,  as 
measured by pulse  width, frequently will  be  longer for the  doublet than the 
single cell, while the total area under the signal peak could be similar. Thus, to 
discriminate between single cells with S+G~/M DNA content and the artifactual 
clumps with doubled or higher multiple DNA content, these gating parameters 
were useful. The gate that was used extended along the pulse area axis to include 
at least the region where single cell GJM  fluorescence would occur.  For this 
reason, a  few of these clumped doublets were necessarily included in the gate, 
while most of the clumps with a pulse width greater than that detected for the 
majority of single cells were excluded. This artifact can be seen in the last column 
of Table II and will be discussed below. 
The analysis of the peripheral blood T  cells of one individual studied in this 
manner  is  displayed in  Fig.  3.  The  FITC-GAMG antibody control,  Fig.  3A, 
demonstrated that almost all counts are clustered in the region where there is 
no FITC surface fluorescence or G0/G1 in the cell cycle (region 1). Analysis with 
mAb  9.6,  Fig.  3B,  showed  that  almost  all  of the  cells  possessed  the  sheep 
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FIGURE  3.  Simultaneous determination of DNA fluorescence using propidium iodide for cell 
cycle analysis and F1TC fluorescence for indirect immunofluorescence of surface antigens of 
T  lymphocytes. All samples were stained with saturating amounts of propidium iodide and 
different mAb against surface antigens as described in Materials and Methods. In each panel 
the lines discriminating beteen G0/G1 and S+G~/M cells are included.  Additionally, the line 
separating surface fluorescence-positive and -negative regions is included to define the four 
possible compartments: (1) G0/Gl nonfluorescent, (2) G0/Gl fluorescent, (3) S+G~/M nonflu- 
orescent, and (4) S+G~/M fluorescent. (A) Normal T  cells stained with the second antibody, 
FITC GAMG, alone. (B) Normal T  cells stained with mAb 9.6, which reacts with the sheep 
erytbrocyte receptor. (C) Normal T  cells stained with mAb $511.  (D) $511-enriched T  cell 
line derived from the same individual stained with mAb $511. 1456  RESTING T  CELL  ACTIVATION BY  ANTIRECEPTOR ANTIBODY 
erythrocyte receptor and were present exclusively in the G0/G1 state (region 2), 
confirming the data obtained with the FITC-GAMG control. When T  cells were 
stained  with  mAb $51 1  (Fig.  3C),  1.5%  of the  cells were surface fluorescence 
positive and all were G0/G1 (region 2).  No $511  fluorescent cells were detected 
in the region of activated cells (region 4). To confirm the ability of this technique 
to  detect  cycling  cells,  an  IL-2-dependent  cell  line  enriched  for  $511  antigen 
expression, which had been derived from the same donor as the normal T  cells, 
was analyzed in an identical manner (Fig.  3D). This cell line demonstrated that 
$511 ÷ cells can be detected  in the  S+Gz/M phase of the cell cycle as well as in 
the G0/Gl phase. 
All  three  individuals  used  for  the  initial  stimulation  studies  (Fig.  1)  were 
analyzed  using  this  technique  to  ensure  that  no  difference  existed  in  the  cell 
cycle of the various $511  populations. These data are presented in Table II and 
confirm the results described above. All samples failed to demonstrate any cells 
in  the  FITC-nonfluorescent  cycling  cell  compartment.  As  before,  the  FITC- 
GAMG  control  and  the  mAb  9.6  demonstrated  that  FITC-fluorescent  and 
-nonfluorescent  cells were present  only in  G0/G~.  The mAb $511  stained  1.5- 
2.6%  of  the  circulating  T  lymphocytes,  all  of  which  were  in  G0/GI.  This 
percentage of $511-reactive cells correlated very well with our previous report 
of the amount of circulating $511-reactive cells.  For all three individuals and all 
three  surface stains,  a  population  of 0.9-1.4%  was consistently detected  in  the 
surface  FITC fluorescence-positive cycling cell compartment.  This percentage 
is related to the small number of doublets included  in the initial gate described 
above and thus represents nonspecific background counts. This interpretation is 
TABLE  II 
Surface Immunofluorescence and Simultaneous Cell Cycle Analysis of Normal T Lymphocytes 
Sample*  Antibody 
Percentage of cells in compartment: 
Surface fluo-  Surface fluo-  Surface fluo-  Surface fluo- 
rescence (-)  rescence (+)  rescence (-)  rescence (+) 
G0/Gl  G0/G1  S+G~/M  S+G~/M 
FITC-GAMG*  97.9  0.9  0.1  1.0 
mAb 9.6  a  10.5  88.4  0  1.1 
mAb $511  96.3  2.6  0.1  0.9 
FITC-GA MG  98.4  0.1  0.1  1.4 
mAb 9.6  10.6  88.2  0  1.2 
mAb $511  97.2  1.8  0.1  0.9 
FITC-GAMG  98.5  0.4  0.1  1.0 
mAb 9.6  8.6  90.4  0  1.0 
mAb $511  97.5  1.5  0  0.9 
4  mAb $511  20.8  50.7  0.7  27.4 
* Samples 1-3 are normal T cells; sample 4 is an IL-2-dependent T cell line derived from donor of 
sample 3. 
~: FITC goat anti-mouse Ig, used alone or as the second antibody in indirect immunofluorescence. 
§ mAb 9.6 recognizes the sheep erythrocyte  receptor. BIGLER,  POSNETT,  AND  CHIORAZZI  1457 
supported by the finding that this value does not change for any of the surface 
stains and, specifically, does not increase with the $511  stain, as would be the 
case if any $511 ÷ cells were activated. Thus, the $511-reactive T  cells  exist in 
the G0/G~ phase. These cell cycle studies of the circulating $511-bearing cells, 
plus the lack of preferential expansion of $511-bearing cells when activated by 
PHA or IL-2 described in the immunofluorescence studies above, indicate that 
the $511-reactive T  lymphocyte does not demonstrate evidence of prior activa- 
tion. 
Isolation and Expansion  of S51I-reactive  T  Lymphocytes.  The $511-bearing T 
cell population from normal individuals was isolated by binding to $511-Sepha- 
rose.  Five  normais were  studied and,  in  each  case,  the  $511-bearing  T  cells 
proliferated  after  $511-Sepharose  exposure.  These  S511-reactive  cells  were 
expanded in  IL-2-containing media and analyzed between days  14  and 21  by 
immunofluorescence. In  each  case at least  60%  $511 ÷ cells could be  demon- 
strated. When these lines were examined for expression of OKT-4 and OKT-8, 
both surface markers were detected (data not shown), suggesting that these early 
cell  lines are  polyclonal with respect  to surface phenotype and that the  $511 
marker is not restricted to a specific T  celt subset. One line was passaged for >2 
months in  IL-2-containing medium with periodic addition of $511-Sepharose. 
An aliquot of cells removed from this culture at that time was freed of $511- 
Sepharose and  grown  in  IL-2  medium  for  24  h  to  avoid  modulation of the 
antigen. When these cells were stained with the $511  mAb and analyzed by flow 
cytometry, >90% of the cells in culture were $511 + (Fig. 2D). This enrichment 
and expansion of the reactive cells permitted the analysis of the surface molecules 
bearing the $511  epitope. 
Initial  Characterization  of the  $511  Antigen  Present  on  a  Polyclonal  T  Cell 
Line.  This cell  fine was  analyzed before cloning to investigate two questions 
regarding the structure of the normal $511  molecule. First, since the molecule 
expressed on  the  original leukemic T  cells  differed slightly from most other 
molecules described,  did  normal  cells  express  a  similar  molecule or  did  the 
malignant clone synthesize a defective molecule? Second, did the $511  molecule 
on these normal cells exhibit molecular heterogeneity in this uncioned popula- 
tion? The molecule present on the $511-bearing leukemic T  cells was compared 
with the molecules present on the normal cell line, using immunoprecipitation 
and SDS-PAGE analysis (Fig. 4). The mobility of the unreduced molecule on the 
leukemic cells  was  77  kD  (compared  with  human  transferrin as  a  molecular 
weight marker) which is compatable with our previous reports. After reduction 
this  molecule was  shown  to  be  a  heterodimer composed of two  chains,  with 
mobilities of 43 and 38 kD.  In contrast to the single molecule on the leukemic 
cells, the unreduced molecules immunoprecipitated by $511  from the cell line 
migrated as a diffuse band between 77 and 90 kD. When these molecules were 
reduced, the heterodimeric structure was present; however, the mobility of the 
two chains was not identical to that of the chains present on the leukemic cell. 
The heavier chain showed a greater heterogeneity of  mobility, migrating between 
43 and 55  kD, while the lighter chain migrated between 38 and 40 kD. Thus, 
by immunoprecipitation and SDS-PAGE analysis, it appears that normal $51 l- 1458  RESTING  T  CELL  ACTIVATION  BY  ANTIRECEPTOR  ANTIBODY 
FIGURE 4.  SDS-PAGE analysis after immunoprecipitation using mAb $511  of ~SI-labeled 
surface  molecules  from  the  original  leukemic  cells  (lanes  1  and  3)  or  a  polyclonal  IL-2- 
dependent,  $51 l-bearing T  cell  fine  from  a  normal  individual  (2  and  4).  Samples  were 
electrophoresed  using  nonreducing  (1  and  2)  or  reducing  (3  and  4)  conditions.  A  band 
migrating at 105 kD in 2 and 4 was not influenced by reduction and its significance is unclear. 
The position of the molecular weight markers is indicated. These were human transferrin (79 
kD), bovine albumin (69 kD), ovalbumin (43 kD), and trypsinogen (24 kD). 
bearing T  cells possess a  surface receptor molecule comparable  in structure  to 
that on the leukemic cells, but with greater molecular variability. 
Discussion 
The present study used mAb $511  previously shown (4) to crossreact with a 
determinant of the T  cell antigen receptor expressed on ~2%  of circulating T 
cells from all individuals tested to date. Since this epitope is present on cells from 
all normal individuals, the mAb does not appear to bind to an allotypic marker 
like that described for the murine T  cell antigen receptor (13). Our experiments 
attempted to answer several  questions about  the  normal  $511-bearing  T  lym- 
phocytes. First, could these cells be specifically stimulated by the antibody and 
did they show evidence of activation before antibody exposure? Second, how did 
the T  cell antigen receptor of the normal  $511 + T  cells compare  with that of 
the leukemic T  cells? 
The ability of mAb $511  to activate normal $511-reactive T  cells in a manner 
analogous to antigen stimulation was investigated using soluble $511  antibody. 
Proliferation was  induced in  a  time- and  concentration-dependent  manner by 
culturing normal T  cells ifi the presence of $511  mAb and irradiated non-T cells 
as accessory cells. In contrast, an anti-DNP mAb and a previously described mAb 
(S160) that reacts with a private idiotope on the $511-bearing leukemic cells (4), 
failed to induce proliferation under these same conditions. Several observations 
suggested  that mAb  S511  was acting directly on  $511 + T  cells to cause  their B1GLER, POSNETT, AND CHIORAZZ1  1459 
proliferation.  The small proliferation index on day 3, when compared with that 
of PHA, implies that only a  few cells were proliferating at this point.  Extensive 
proliferation of $511 + cells was suggested when the peak proliferation  index of 
$511  cultures  (61  on day 7) was compared  with  the peak  value obtained  with 
PHA (222  on day 3).  Immunofluorescence analysis demonstrated  that  34%  of 
the  cells in  these  $511  cultures  were $511 + after  7  d.  T  cells nonspecifically 
activated by PHA  or by IL-2  failed  to demonstrate  preferential  expansion  of 
these  $511-bearing  T  lymphocytes.  Thus,  a  selective  expansion  of the  $511 
population,  rather  than  nonspecific cell recruitment,  appears to be responsible 
for most of this brisk proliferative response. 
Activation  of normal  T  lymphocytes by the  antigen  receptor  has  not  been 
previously  reported  using  either  mAb  or  antisera  reacting  with  the  antigen 
receptor (1-6,  11-13).  Normal T  lymphocytes, however, have been induced to 
proliferate  by OKT-3  (16,  17).  Since  the  T3  molecule co-modulates with  the 
antigen receptor molecule (2, 4, 5) and is closely associated with the 43 kD beta 
chain (18), this nonclonally restricted, T3-induced activation probably uses the 
same  mechanism  as  antigen  receptor-induced  proliferation.  Thus,  the  major 
differences between the activation of normal T  cells by OKT-3 and $511 are the 
number of cells activated and the molecule within the antigen receptor complex 
that is bound by the mAb.  The different kinetics of $511  activation compared 
with  OKT-3  activation  probably  reflect  the  small  number  of cells  activated, 
similar to the proliferation of small populations in antigen-specific systems (19- 
21) or mixed lymphocyte reactions (22, 23). 
Our  initial  studies of $511-induced  activation  used T  cells and  a  small  per- 
centage  of  irradiated  nonrosetting  cells  to  function  as  accessory  cells.  The 
requirement  for  these  additional  cells  was  investigated  by  culturing  T  cell 
preparations  alone  with  antibody.  Results indicated  that  there  were no  major 
differences  in  the  extent  of proliferation  generated  with  or  without  added 
accessory cells. T  cells alone were also used in developing $511-reactive lines by 
$511-Sepharose activation.  Previous studies (5) in this laboratory have demon- 
strated  that  leukemic  T  cells  containing  <1%  monocytes  can  be  induced  to 
proliferate  by  an  anti-T  cell  receptor  mAb.  Studies  using  T  cell  lines  and 
hybridomas also may not require the addition of accessory cells to induce clonal 
proliferation by clonotypic mAb (2, 6, 24). Similarly, an alternate pathway of T 
cell activation  using mAb reacting with the T11  molecule may not require the 
presence of monocytes (25). Since the rosetted T  cells used in our experiments 
probably contain a few monocytes, and since the $511 mAb is IgG2b and would 
be expected to bind  fairly well to  Fc receptors of accessory cells, the absolute 
requirement  for these cells cannot  be determined  from our studies.  However, 
the above-mentioned observations together  suggest that  accessory cell popula- 
tions may not be essential for antibody-induced activation. 
Several laboratories, including our own, have shown (2, 3, 5, 6,  13) that, when 
T  cell lines,  hybridomas,  or leukemias were cultured  in the presence of either 
soluble or Sepharose-bound  anti-T  cell  receptor  mAb,  a  specific proliferative 
response could be generated.  In each of these systems, the target T  cells were 
previously activated. The $511-bearing normal cells were studied to determine 
if these  cells  were  similarly  activated.  By  cell  cycle analysis  at  least  98%  of 1460  RESTING  T  CELL  ACTIVATION  BY  ANTIRECEPTOR  ANTIBODY 
circulating T  cells were present in  the G0/G~  phase, and all $511-reactive cells 
were  in  G0/G1.  These  findings,  based  on  DNA  analysis  of individual  $511- 
bearing cells, are in agreement with studies by Darzynkiewicz et al. (26, 27) and 
previous  work (reviewed in  28)  that  simultaneously analyzed  DNA  and  RNA 
content of cells and demonstrated that circulating  lymphocytes are normally in 
the  Go or  Glq  phase  (27).  Since  the  Tac  antigen  has  been  shown  (29)  to  be 
expressed  8-16  h  after  activation  even  without  an  increase  in  cellular  DNA 
content, cells were cultured  in  IL-2-containing media as a  different method of 
detecting activation.  Immunofluorescence  analysis demonstrated  that  no pref- 
erential  increase in the $511-reactive cells occurred.  These two results suggest 
that  the  S511-reactive  cells  are  not  activated  in  vivo.  The  possibility  of a 
nonquantifiable  degree of preactivation,  however,  cannot  be totally excluded, 
since the assays used sheep erythrocyte-rosetted T cells and, as mentioned above, 
the erythrocyte receptor has been implicated as an alternate pathway of T  cell 
activation (25). Thus, the present study extended our prior observations on the 
presence  of a  small  S511-reactive  population  in  the  circulation  of normals, 
demonstrating the lack of prior quantifiable activation of these cells. 
The  ability  to  stimulate  normal  $511-reactive  T  lymphocytes was  used  to 
develop IL-2-dependent  cell  lines  expressing  the  $511  epitope.  The  leukemic 
$511  molecule  has  been  shown  to  differ  from  most  other  antigen  receptor 
molecules in  the mobility of the two chains (43 and  38 kD) and  the isoelectric 
points (pI) of each chain (near neutral pI) (1-6). SDS-PAGE analysis of the $511- 
bearing normal T  cell line demonstrated that the relative mobility of the $511 
molecule  that  was  derived  from  normal  cells  was  comparable  to  that  of the 
molecules  on  the  leukemic  cells.  Thus,  a  subset  of normal  T  lymphocytes 
routinely synthesizes this form of antigen  receptor molecule, implying that  the 
disparity in  mobility cannot be ascribed to a  biosynthetic defect present in the 
malignant cells. One possible explanation for these differences is the presence of 
differences in  glycosylation. That  glycosylation accounts for a  large portion  of 
the molecular weight of the T  cell antigen  receptor has become evident from 
recent studies (7-10,  30).  If this is the basis for the mobility differences in the 
$511 molecule, then $511 ÷ normal cells glycosylate either one or both polypep- 
tide  chains  differently  than  most other antigen  receptor  molecules described. 
Since  differential  glycosylation can  modulate  the  function  of a  common  IgE- 
binding  factor  (31)  and  sugar  moieties  play  a  role  in  immune  regulation  by 
suppressor T  cells (32,  33), differences in glycosylation of the antigen receptor 
may have a  functional  significance.  Another explanation  for the differences in 
mobility  is  the  synthesis  of a  polypeptide  different  than  those  previously de- 
scribed.  Although  current  evidence  does not  suggest  the  existence  of T  cell 
receptor isotypes, recent studies indicate that this possibility cannot be completely 
excluded (34, 35). Both of these possible explanations are under study. 
Summary 
A previous study from this laboratory described a monoclonal antibody, $511, 
that reacted with the T  cell antigen  receptor on a  human  T  cell leukemia and 
also on  1-2% of circulating T  lymphocytes in all normal individuals tested. The 
data presented in the present study demonstrate  that,  when normal T  lympho- BIGLER,  POSNETT,  AND  CHIORAZZI  1461 
cytes are  cultured  with  or  without  irradiated  non-T  cells  in  the  presence  of 
soluble $511  antibody, a concentration- and time-dependent proliferation of the 
$511-reactive population  occurred.  Proliferation  indices  as  high  as  184  times 
greater than control were observed, which represents a major stimulatory effect 
on the initially minor $511 + subset.  When $511 + ceils were studied for evidence 
of prior activation, they were shown to be unresponsive to interleukin  2  (IL-2) 
unless exposed to $511  antibody, and were shown to be in the G0/Gl phase of 
the  cell  cycle. Thus,  the  $511  antibody activated  resting  normal  T  cells  in  a 
manner analogous to specific antigen binding to the T  cell antigen receptor. 
The leukemic $511  molecule has been shown previously to differ from most 
other antigen receptors in the mobility of the two chains at 43 and  38 kD and 
the neutral isoelectric point of each chain. Expansion of reactive normal cells by 
$511-Sepharose  permitted  the  development  of  IL-2-dependent  T  cell  lines 
enriched for $511-bearing  cells.  The antigen  receptor molecules on one such 
polyclonai $511-enriched T  cell line were immunoprecipitated with $511  anti- 
body and  shown  to have comparable mobility to that present on the  leukemic 
cells, but to possess a greater heterogeneity of mobility. Thus, the leukemic cells 
and  normal  cells express similar T  cell receptor molecules. The differences in 
the  $511  T  cell  antigen  receptor  molecule  possibly  relate  to  differences  in 
glycosylation or polypeptide structure. 
We would like to thank Dr. Frank Traganos for his expert assistance with the cell cycle 
analysis and Mr. Peter Pasley for his excellent technical assistance. 
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